LONDON: As more countries took steps to bar the entry of a new coronavirus variant, the head of drugmaker AstraZeneca, which is developing a vaccine widely expected to be approved by United Kingdom authorities this week, on Sunday (Monday in Manila) said researchers believed the shot would be effective against a new variant of the virus driving a rapid surge in infections in Britain.

Jacques Collineau, 75, receives a dose of the Pfizer-BioNTech Covid-19 vaccine at Debrou nursing home (Ephad) in Joue-les-Tours, near Tours, on December 28, 2020 as France started its national vaccination campaign to fight against the spread of the novel coronavirus. AFP Photo

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details